“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis

Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica

(2012) Ingo Kleiter   ARCHIVES OF NEUROLOGY

Does natalizumab therapy worsen neuromyelitis optica?

(2012) A. Jacob et al.   NEUROLOGY

Conventional brain MRI in neuromyelitis optica

(2011) J. A. Cabrera-Gomez et al.   EUROPEAN JOURNAL OF NEUROLOGY

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder

(2011) Ju-Hong Min et al.   Multiple Sclerosis Journal

Interferon Beta Treatment in Neuromyelitis Optica

(2010) Jacqueline Palace et al.   ARCHIVES OF NEUROLOGY

“Cloud-like enhancement” is a magnetic resonance imaging abnormality specific to neuromyelitis optica

(2009) Shoichi Ito et al.   ANNALS OF NEUROLOGY

Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis

(2009) A. Uzawa et al.   EUROPEAN JOURNAL OF NEUROLOGY

Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study

(2009) Wolfgang Krampla et al.   EUROPEAN RADIOLOGY

Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay

(2008) Sei Hayakawa et al.   JOURNAL OF NEUROIMMUNOLOGY

Preferential spinal central gray matter involvement in neuromyelitis optica

(2008) M. Nakamura et al.   JOURNAL OF NEUROLOGY